Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04488003
Brief Title: Study of Ulixertinib for Patients With Advanced Malignancies Harboring MEK or Atypical BRAF Alterations

First Submitted : July 17, 2020
First Submitted that Met QC Criteria : July 24, 2020
First Posted : July 27, 2020

Last Update Submitted that Met QC Criteria : August 30, 2021
Last Update Posted : September 1, 2021